If your hospital is evaluating registry abstraction support, Q-Centrix is likely a name you have already encountered. But Q-Centrix has changed significantly since its acquisition by MRO Corp. in 2025. The combined entity now positions itself as an enterprise clinical data management platform, with a heavy emphasis on proprietary technology, AI-assisted abstraction, and large-scale health system deployments.
For some organizations, that direction may be a strong fit. For many hospitals, though, it raises a straightforward question: Is there a better Q-Centrix alternative that delivers accurate, human-led registry abstraction without the complexity and cost of an enterprise platform implementation?
Clinical Registry Solutions (CRS) is exactly that partner. CRS is a focused, registry-specific abstraction company built for hospitals that need accurate, human-led support without enterprise overhead.
In this guide, we break down how CRS and Q-Centrix differ on abstraction model, registry coverage, onboarding speed, cost, and overall fit so your team can make a confident, informed decision.
What is Q-Centrix?
In June 2025, MRO Corp. acquired Q-Centrix, creating a combined company that describes itself as “The Single Source for Smarter Data.” The Q-Centrix offering is now positioned as part of MRO’s broader clinical data ecosystem, which includes release of information, revenue integrity, clinical research enablement, and data management consulting alongside registry abstraction.
The Q-Centrix abstraction solution is built around the company’s Enterprise Clinical Data Management (eCDM) platform, a proprietary system that centralizes abstraction workflows, validation, and submission. MRO has also introduced Prodigy, an AI engine designed to augment the abstraction process within that platform. The stated model is one of “Collaborative Intelligence,” combining human expertise and AI within a unified technology environment.
Their service lines cover cardiology, oncology, quality improvement, trauma, and specialty registries. The emphasis in their marketing is on organizations that want to centralize data management across multiple programs and facilities within one platform.
For health systems managing dozens of programs across many facilities and looking for centralized enterprise analytics, Q-Centrix and MRO may genuinely be worth evaluating. The question hospital teams should ask is whether that model matches what their program actually needs right now.
What Are the Disadvantages Of Q-Centrix?
Not every hospital is an enterprise health system looking to centralize data operations across 20 facilities. Many hospitals evaluating registry abstraction support have much more immediate and specific concerns.
They need a backlog cleared before the next submission deadline. They lost an abstractor to turnover and need coverage within the week. They want accurate, audit-ready data across a handful of registries without adopting a new platform or navigating an IT implementation. They need cost savings they can show a CFO, not a long-term technology investment that requires internal buy-in across multiple departments.
For programs in any of those situations, an enterprise platform model introduces friction where you need speed. It creates technology dependencies where you need flexibility. And it can add cost where you are already under budget pressure.
Cost is one of the most consistent concerns hospital teams raise when evaluating Q-Centrix. Since the MRO acquisition, pricing has increased significantly, and the addition of the Prodigy AI platform has not reduced what hospitals pay. If anything, the technology layer has added further expenses. For budget-conscious quality programs, that trajectory is difficult to justify.
There is also the matter of platform risk. Any cloud-based system carries the possibility of downtime, and when your abstraction workflow runs entirely inside a proprietary platform, an outage does not just create an inconvenience. It can halt submissions, delay data entry, and put your program’s deadlines at risk in ways that a more flexible, system-agnostic model simply does not.
Scale is another factor worth considering. MRO is a large enterprise company serving thousands of hospitals across multiple product lines. For some organizations, that scale is reassuring. For others, it means your registry program is one of many accounts in a very large portfolio. Service delivery, responsiveness, and the feeling of having a dedicated partner can look quite different depending on how a company of that size structures its client relationships.
CRS is a specialized clinical registry abstraction partner built for hospitals that want experienced human abstractors, fast onboarding, and no proprietary software requirements. That means the people supporting your program are focused specifically on registry abstraction, and your account is not competing for attention against hundreds of other service lines.
→ Is your hospital dealing with a registry backlog, a staffing gap, or an upcoming submission deadline? Contact CRS to learn how we support programs across 25+ registries with onshore abstractors who can be onboarded in days.
Why is CRS a Strong Q-Centrix Alternative?
CRS has supported more than 100 hospitals across more than 25 clinical registries. Every abstractor on the CRS team is clinician-trained, U.S.-based, and onshore. There is no offshore abstraction and no AI engine making the clinical judgment calls. The people reviewing your charts understand registry definitions, documentation nuance, and what accurate abstraction actually requires.
CRS maintains a validated Inter-Rater Reliability (IRR) accuracy rate of 98.3% or higher across all supported registries. IRR is a measurable, auditable standard, and CRS monitors it continuously as part of its quality program. Hospitals preparing for registry audits or working to improve their own IRR performance benefit directly from that level of accountability.
CRS is also platform agnostic. The team works inside your existing EMR, whether that is Epic, Cerner, Meditech, or another system, and within whatever registry platform your program already uses. There is no new software to implement, no IT project to scope, and no training burden placed on your internal team. You get abstraction support that fits into your existing workflow from day one.
Most programs can be onboarded within days. For a hospital dealing with a coverage gap or a growing backlog, that matters. The alternative to fast deployment is weeks or months of data falling further behind while an enterprise implementation gets configured.
On cost, CRS delivers an average of 30% or more in savings compared to maintaining in-house abstraction staff. When you account for the full cost of an internal abstractor, including salary, benefits, PTO, overtime, training, and turnover, outsourcing to CRS typically represents a meaningful reduction in total program expense.
For more on how hospitals should be thinking about those numbers, the CRS resource on measuring the ROI of clinical registry participation walks through the full cost comparison framework.
→ Is abstraction accuracy a concern for your program, or is IRR monitoring something your current model lacks? Reach out to CRS to learn how we maintain 98.3%+ IRR across every registry we support.
What Registry Coverage Does CRS Support?
One practical consideration when evaluating a Q-Centrix alternative is whether the partner can cover the specific registries your program participates in. CRS supports more than 25 clinical registries across multiple specialties, and that breadth is one of the reasons hospitals with multi-registry programs choose CRS as their abstraction partner.
On the cardiac side, CRS provides dedicated support for ACC NCDR registries, including CathPCI, Chest Pain-MI, ICD, and LAAO. CRS also supports AHA Get With The Guidelines (GWTG) programs covering stroke, heart failure, coronary artery disease, and atrial fibrillation, as well as the STS Adult Cardiac Surgery Database.
Beyond cardiac, CRS covers cancer registry support including NCDB and state registry programs, MBSAQIP for bariatric programs, NSQIP for surgical quality, the PC4 Pediatric Cardiac Critical Care Consortium, and Core Measures abstraction.
For hospitals managing several registries across different service lines, working with a single abstraction partner that covers all of them reduces vendor complexity and creates consistency in accuracy and process. The article on standardizing clinical registry data across multi-hospital systems covers how hospitals with multiple programs benefit from a coordinated abstraction approach.
→ Does your hospital participate in multiple registries across different service lines? Contact CRS to discuss how we can support your full registry program with one consistent abstraction team.
Human Abstraction vs. AI-Assisted Abstraction: What Hospitals Should Understand
Q-Centrix describes its model as “Collaborative Intelligence,” meaning human abstractors working alongside AI tools within the eCDM platform. MRO has introduced the Prodigy AI engine as part of that framework. This approach is clearly central to their current direction and investment.
CRS takes a different position. Every abstraction decision at CRS is made by a clinician-trained human abstractor. There is no AI layer making preliminary determinations that a human then reviews. The abstractors at CRS bring clinical nursing backgrounds and registry-specific training to every case they touch.
The practical implication for hospitals comes down to accuracy and accountability. When your program undergoes a registry audit or your IRR scores come under review, the question is always whether your data is defensible. Human-led abstraction with continuous IRR monitoring gives you a clear answer.
CRS validates accuracy at 98.3% or higher across all registries, and that standard is maintained through ongoing quality review, not through algorithmic processing.
Some programs may find that AI-assisted models work well for their needs. Others, particularly those with complex cases, multi-source documentation challenges, or audit exposure, tend to place a higher premium on clinical judgment in the abstraction process. Understanding which situation applies to your program is the right place to start.
For a deeper look at why data integrity in the abstraction process matters for registry outcomes, the CRS article on ensuring data integrity in clinical registries is a useful reference.
Flexibility and Engagement Model: A Practical Comparison
Q-Centrix, as part of MRO, is structured around an enterprise model. Their platform is designed to scale across large health systems and is positioned as a long-term infrastructure investment. That architecture makes sense for the customers they are targeting.
CRS is structured for flexibility. Hospitals can engage CRS for full-service outsourced abstraction, supplemental support alongside an existing internal team, backlog clearance for programs that have fallen behind, or audit preparation for programs facing review. Engagement terms are flexible, and there are no proprietary platform requirements or technology adoption hurdles standing between your program and the support it needs.
This flexibility is especially valuable during periods of transition. When a hospital loses an experienced abstractor, the gap in data can compound quickly. Backlogs grow, submission deadlines approach, and accuracy suffers when remaining staff are stretched. CRS can step in quickly to cover the gap without a drawn-out procurement and implementation process.
CRS also offers remote data abstraction services for hospitals that want experienced abstractors working within their systems without requiring on-site staffing arrangements. That model works inside your existing workflow with no disruption to your team’s day-to-day operations.
→ Is your hospital dealing with abstractor turnover, a growing backlog, or pressure to reduce registry program costs? Contact CRS to explore engagement options that fit your program’s immediate needs without long-term platform commitments.
CRS vs. Q-Centrix: Which Partner Is the Right Fit?
The honest answer is that Q-Centrix and CRS serve different hospital profiles, and the right choice depends on what your program actually needs.
If your health system is looking to centralize clinical data management across dozens of programs, wants enterprise-level analytics, and is prepared to invest in platform implementation and ongoing technology integration, Q-Centrix as part of MRO is a credible option to evaluate.
If your hospital needs accurate, human-led registry abstraction across one or several programs, wants to avoid proprietary software adoption, requires fast onboarding, and is looking for meaningful cost savings compared to in-house staffing, CRS is built for exactly that.
CRS supports more than 100 hospitals, maintains 98.3%+ IRR accuracy, covers 25+ registries, deploys within days, and delivers 30% or more in average cost savings. There are no platform dependencies, no offshore abstractors, and no enterprise implementation timeline standing between your program and the support it needs. Contact the team to request a proposal.
Finding a Q-Centrix Alternative: FAQs
What is a Q-Centrix alternative for clinical registry abstraction?
A Q-Centrix alternative is any abstraction partner that can support hospital registry programs with accurate, timely data abstraction. CRS is a specialized alternative focused on human-led, clinician-trained abstraction across 25+ registries, without proprietary platform requirements.
How does CRS compare to Q-Centrix in registry coverage? CRS supports more than 25 clinical registries across cardiac, cancer, surgical, bariatric, pediatric, stroke, and quality reporting programs. Coverage includes ACC NCDR, AHA GWTG, STS, NSQIP, MBSAQIP, NCDB, PC4, Core Measures, and additional specialty registries.
Does CRS require hospitals to adopt new software or a proprietary platform?
No. CRS is platform agnostic and works within your existing EMR and registry systems. There is no software to implement, no IT project to manage, and no training burden placed on your internal team.
How quickly can CRS onboard a hospital registry program?
Most CRS programs onboard within days. For hospitals dealing with backlogs, coverage gaps, or urgent submission deadlines, that speed is a significant operational advantage over vendors that require lengthy implementation timelines.
How does CRS maintain abstraction accuracy?
CRS uses clinician-trained, U.S.-based abstractors with registry-specific training and maintains a validated IRR accuracy rate of 98.3% or higher. Accuracy is monitored continuously through an ongoing quality review process across all supported registries.
Can CRS support hospitals that are currently using Q-Centrix and want to switch?
Yes. CRS can take over full-service abstraction or provide supplemental support for programs transitioning from any existing vendor. The onboarding process is designed to minimize disruption to your submission schedule.
How does CRS pricing compare to Q-Centrix?
CRS does not publish Q-Centrix pricing, as that information is not publicly available. What CRS can demonstrate is that hospitals typically achieve 30% or more in cost savings compared to maintaining in-house abstraction staff, and CRS’s flexible engagement model avoids platform licensing costs that may be associated with enterprise technology solutions.
What types of hospitals is CRS best suited for?
CRS works well for community hospitals, regional medical centers, and health systems of all sizes that need accurate registry abstraction without enterprise-level technology commitments. Programs facing staffing gaps, submission backlogs, audit exposure, or cost pressure tend to find CRS’s model the right fit.
The Bottom Line
The registry abstraction market has changed. Q-Centrix is now part of a larger enterprise clinical data management company with a clear focus on large health systems and platform-driven solutions. That may be the right direction for some organizations. For hospitals that need flexible, accurate, human-led abstraction support without a complex technology implementation, the better path is a Q-Centrix alternative built specifically for registry programs.
CRS supports more than 100 hospitals across more than 25 registries with clinician-trained, onshore U.S.-based abstractors, validated 98.3%+ IRR accuracy, and engagement models that can be active within days. If your program is evaluating options, CRS is ready to talk through what the right level of support looks like for your specific registries and timeline.
